The weekly litigation news digest is live. Subscribe now

IP Verse

Virion-Like Delivery Particles For Self-Replicating Rna Molecules - EP4005592

The patent EP4005592 was granted to Glaxosmithkline on Oct 12, 2022. The application was filed on Jul 6, 2011 under application number EP21204155A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4005592

GLAXOSMITHKLINE
Application Number
EP21204155A
Filing Date
Jul 6, 2011
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MARGARET DIXONJul 12, 2023MEWBURN ELLISWITHDRAWN
THOMANNJul 11, 2023THOMANNADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP2590676
OPPOSITIONUS2011200667
OPPOSITIONWO0000617
OPPOSITIONWO02095023
OPPOSITIONWO0209645
OPPOSITIONWO2007047749
OPPOSITIONWO2009146867
OPPOSITIONWO2010015098
OPPOSITIONWO2012006369
OPPOSITIONWO2012006372
OPPOSITIONWO2012006376
OPPOSITIONWO2012006377
OPPOSITIONWO2012006378
OPPOSITIONWO2012030901
OPPOSITIONWO2012031043
OPPOSITIONWO2012031046
SEARCHWO02061113

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents